These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33266371)

  • 1. Neurohormonal Modulation as a Therapeutic Target in Pulmonary Hypertension.
    García-Lunar I; Pereda D; Ibanez B; García-Álvarez A
    Cells; 2020 Nov; 9(11):. PubMed ID: 33266371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomic nervous system involvement in pulmonary arterial hypertension.
    Vaillancourt M; Chia P; Sarji S; Nguyen J; Hoftman N; Ruffenach G; Eghbali M; Mahajan A; Umar S
    Respir Res; 2017 Dec; 18(1):201. PubMed ID: 29202826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure.
    Ameri P; Bertero E; Meliota G; Cheli M; Canepa M; Brunelli C; Balbi M
    Heart Fail Rev; 2016 Sep; 21(5):539-47. PubMed ID: 27206576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension.
    Huang Y; Liu YW; Pan HZ; Zhang XL; Li J; Xiang L; Meng J; Wang PH; Yang J; Jing ZC; Zhang H
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):704-718. PubMed ID: 30816802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system.
    Liu C; Jiang XM; Zhang J; Li B; Li J; Xie DJ; Hu ZY
    BMC Cardiovasc Disord; 2016 Oct; 16(1):192. PubMed ID: 27724864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible?
    Emdin M; Fatini C; Mirizzi G; Poletti R; Borrelli C; Prontera C; Latini R; Passino C; Clerico A; Vergaro G
    Clin Chim Acta; 2015 Mar; 443():85-93. PubMed ID: 25445411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension.
    da Silva Gonçalves Bos D; Happé C; Schalij I; Pijacka W; Paton JFR; Guignabert C; Tu L; Thuillet R; Bogaard HJ; van Rossum AC; Vonk-Noordegraaf A; de Man FS; Handoko ML
    JACC Basic Transl Sci; 2017 Feb; 2(1):22-35. PubMed ID: 29034356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?
    de Man FS; Handoko ML; Guignabert C; Bogaard HJ; Vonk-Noordegraaf A
    Am J Respir Crit Care Med; 2013 Jan; 187(1):14-9. PubMed ID: 23144327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition.
    Atlas SA
    J Manag Care Pharm; 2007 Oct; 13(8 Suppl B):9-20. PubMed ID: 17970613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal denervation attenuates aldosterone expression and associated cardiovascular pathophysiology in angiotensin II-induced hypertension.
    Hong MN; Li XD; Chen DR; Ruan CC; Xu JZ; Chen J; Wu YJ; Ma Y; Zhu DL; Gao PJ
    Oncotarget; 2016 Oct; 7(42):67828-67840. PubMed ID: 27661131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renin-angiotensin-aldosterone system (RAAS) and its pharmacologic modulation].
    Giestas A; Palma I; Ramos MH
    Acta Med Port; 2010; 23(4):677-88. PubMed ID: 20687997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
    Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
    Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial Effects of Renal Denervation on Pulmonary Vascular Remodeling in Experimental Pulmonary Artery Hypertension.
    Qingyan Z; Xuejun J; Yanhong T; Zixuan D; Xiaozhan W; Xule W; Zongwen G; Wei H; Shengbo Y; Congxin H
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):562-70. PubMed ID: 25804321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Contribution of Carotid Body-Induced Sympathetic and Renin-Angiotensin System Overflow to Pulmonary Hypertension in Intermittent Hypoxia.
    Iturriaga R; Castillo-Galán S
    Curr Hypertens Rep; 2019 Oct; 21(11):89. PubMed ID: 31599367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sympathetic nervous system and the renin-angiotensin-aldosterone system in cardiovascular disease.
    Cody RJ
    Am J Cardiol; 1997 Nov; 80(9B):9J-14J. PubMed ID: 9375943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.
    Maron BA; Leopold JA
    Circulation; 2015 Jun; 131(23):2079-91. PubMed ID: 26056345
    [No Abstract]   [Full Text] [Related]  

  • 18. [Activity of renin-angiotensin-aldosterone system (RAAS) and vasopressin level in patients with primary pulmonary hypertension].
    Martyniuk TV; Chazova IE; Masenko VP; Volkov VN; Belenkov IuN
    Ter Arkh; 1998; 70(4):33-6. PubMed ID: 9612899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sacubitril/valsartan treatment relieved the progression of established pulmonary hypertension in rat model and its mechanism.
    Liu S; Wang Y; Lu S; Hu J; Zeng X; Liu W; Wang Y; Wang Z
    Life Sci; 2021 Feb; 266():118877. PubMed ID: 33310048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic regulation of circadian rhythmicity of the renin-angiotensin-aldosterone system in five subtypes of essential hypertension.
    Cugini P; Manconi R; Mancini A; Serdoz R; Meucci T; Scavo D
    G Ital Cardiol; 1980; 10(2):184-90. PubMed ID: 6102942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.